Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;334:709 (7 April), doi:10.1136/bmj.39169.900475.1F
| The first 150 words of the full text of this article appear below. |
We have identified a potentially distorting factor in the delivery of reductions in Clostridium difficile rates.1 A letter sent to chief executives of trusts, primary care trusts, and strategic health authorities in England in December 2006 stated that the forthcoming NHS operating framework for 2007-8 and the NHS contract require primary care trusts to agree a local target with their acute hospital providers for a significant reduction in C difficile infections.2 The target is expected to be "locally appropriate" and based on "current performance." A reduction of at least 25% was suggested for trusts with a rate greater than 4 cases per 1000 bed days (in people over 65), while maintenance of the current rate would be an appropriate target for trusts with a rate of 1 per 1000 bed days or lower.
The West Midlands Strategic Health Authority initially imposed indicative targets for all acute trusts to negotiate with
M A Cooper, director, infection prevention and control1, P M Hawkey, consultant medical microbiologist2
1 Royal Wolverhampton Hospitals NHS Trust, Department of Microbiology, New Cross Hospital, Wolverhampton WV10 0QP, 2 West Midlands Public Health Laboratory, Birmingham Heart of England NHS Trust, Birmingham B9 5SS
peter.hawkey@heartofengland.nhs.uk